The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2026

Filed:

Aug. 25, 2023
Applicant:

Reflexion Medical, Inc., Hayward, CA (US);

Inventors:

Yevgen Voronenko, Sunnyvale, CA (US);

Maksat Haytmyradov, Hayward, CA (US);

Peter Demetri Olcott, Los Gatos, CA (US);

Lingxiong Shao, Saratoga, CA (US);

Manoj V. Narayanan, Mentor, OH (US);

Assignee:

RefleXion Medical, Inc., Hayward, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/11 (2017.01); A61N 5/10 (2006.01); G06T 7/00 (2017.01); G06T 7/12 (2017.01); G06T 7/70 (2017.01); G06T 7/73 (2017.01);
U.S. Cl.
CPC ...
G06T 7/11 (2017.01); A61N 5/103 (2013.01); A61N 5/1031 (2013.01); A61N 5/1039 (2013.01); G06T 7/0012 (2013.01); G06T 7/12 (2017.01); G06T 7/70 (2017.01); G06T 7/73 (2017.01); A61N 2005/1052 (2013.01); G06T 2207/10081 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/10104 (2013.01); G06T 2207/10108 (2013.01); G06T 2207/10116 (2013.01); G06T 2207/20076 (2013.01); G06T 2207/30096 (2013.01);
Abstract

Disclosed herein are methods and systems for identifying the location of a target region using a tumor identification (ID) profile. A tumor ID profile includes identification parameters that characterize the target region. The tumor ID profile may be used to facilitate the identification of multiple target regions and to evaluate whether it is safe to deliver radiation to the target regions at their updated locations. Also disclosed herein are methods for analyzing a dose distribution to a target region by generating a bounded dose volume histogram (bDVH) based on gamma criteria comprising a distance-to-agreement (DTA) criterion and a dose difference (DD) criterion. In one variation, a gamma-derived bDVH is used in a method for selecting gamma criteria values for evaluating a radiotherapy treatment plan.


Find Patent Forward Citations

Loading…